Northeast Regional Epilepsy Group

Summary

Northeast Regional Epilepsy Group is a medical facility located in Hackensack, New Jersey. This center is recognized for care of Epilepsy, Seizures, Partial Cycloplegia, Lennox Gastaut Syndrome, Myoclonic Astatic Epilepsy and other specialties. Northeast Regional Epilepsy Group is involved with conducting 33 clinical trials across 24 conditions. There are 1 research doctors associated with this hospital, such as Eric Segal, M.D..

Top PIs

Clinical Trials running at Northeast Regional Epilepsy Group

Seizures

Epilepsy

Partial Cycloplegia

Lennox Gastaut Syndrome

Partial Seizures

Myoclonic Astatic Epilepsy

Dravet Syndrome

Hippocampal Sclerosis

Temporal Lobe Epilepsy

Pediatric Epilepsy

Cenobamate

for Epilepsy

Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures

Recruiting

2 awards

Phase 3

12 criteria

XEN1101

for Seizures

This trial tests XEN1101, a medication added to current treatments, in people with generalized epilepsy experiencing PGTCS who are already on 1-3 anti-seizure medications. The goal is to see if taking XEN1101 with an evening meal can help reduce seizure frequency.

Recruiting

1 award

Phase 3

XEN1101

for Partial Seizures

The X-TOLE3 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101 administered as adjunctive therapy in focal-onset seizures.

Recruiting

1 award

Phase 3

4 criteria